OPTOCIRCUI

Opto Circuits (India) Limited has informed the Exchange regarding Limited Review Report (Consolidated) September 30, 2016

Opto Circuits (India) Limited has informed the Exchange regarding Limited Review Report (Standalone) for the period ended September 30, 2016

Opto Circuits (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2016.

Opto Circuits (India) Limited has submitted to the Exchange a Copy of Limited Review Report for June 2016 quarter.

Opto Circuits (India) Limited has informed the Exchange vide letter dated September 16, 2016 regarding a press release , titled" Opto Circuits's wholly owned subsidiary Eurocor Gmbh, enters the Global Market with their FREEWAY COATED SHUNTBALLOON CATHETER".

Opto Circuits (India) Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended June 30, 2016.

Opto Circuits (India) Limited has submitted to the Exchange a copy of voting results of Annual General Meeting of the Company held on September 07, 2016, along with a copy of Scrutinizer's Report.

Opto Circuits (India) Limited has informed the Exchange the Summary of Proceedings of the Annual General Meeting of the Company held on September 07, 2016.

Opto Circuits (India) Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from September 5, 2016 to September 7, 2016 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on September 07, 2016.

Opto Circuits (India) Limited has informed the Exchange regarding the Outcome of Board Meeting of the Company held on July 29, 2016.

Opto Circuits (India) Limited has informed the Exchange vide letter dated July 12, 2016 regarding a press release titled "Opto Circuits' wholly owned subsidiary, Eurocor Gmbh, launches COATED SHUNT BALLOON CATHETER used for DIALYSIS patients which reduces re-intervention and preserves future treatment options".

The Exchange has sought clarification from Opto Circuits (India) Limited with respect to Limited Review Report for the quarter ended December 31, 2015 and on casual vacancy of Auditor.

Opto Circuits (India) Limited has submitted to the Exchange the consolidated financial results along with the Auditors Report for the period ended 31-Mar-2016.

Opto Circuits (India) Limited has informed the Exchange that as per the Company's Code of Conduct for prevention of Insider Trading, the trading window for the purpose of trading in the shares of the Company will remain closed from June 08, 2016 to June 16, 2016 (both days inclusive) inter alia to consider the Financial Results for the quarter and year ended March 31, 2016. The trading window shall open from June 17, 2016.

Opto Circuits (India) Limited has informed the Exchange regarding Outcome of Board Meeting of the Company held on May 30, 2016.

Opto Circuits (India) Limited has informed the Exchange that as per the Company's Code of Conduct for prevention of Insider Trading, the trading window for the purpose of trading in the shares of the Company will remain closed from May 23,2016 to June 01, 2016 (both days inclusive) inter alia to consider the Financial results for the quarter and year ended March 31, 2016. The trading window shall open from June 02, 2016.

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors at their meeting held on April 26, 2016 have appointed Mr. G C Somadas, a Fellow member of the Institute of Chartered Accountants of India, as Additional Director of the Company with effect from April 26, 2016.

Opto Circuits (India) Limited has submitted to the Exchange the standalone & consolidated financial results for the period ended December 31, 2015.

Opto Circuits (India) Limited has informed the Exchange that as per the Company's Code of Conduct for prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will remain closed for all Directors/Officers/Designated employees of the company from February 06, 2016 to February 17, 2016 (both days inclusive) for purpose of declaration of Un-audited Financial Results for the quarter/period ended December 31, 2015.

Opto Circuits (India) Limited has informed the Exchange regarding the voting results of the AGM of the Company held on December 31, 2015.

Opto Circuits (India) Limited has informed the Exchange regarding the proceedings of the Annual General Meeting of the Company.

Opto Circuits (India) Limited has informed the Exchange that, in terms of the approval under Companies Act, 2013, the Company has obtained approval from the Office of the Registrar of Companies (ROC), Karnataka, an extension of time for holding Annual General Meeting (AGM) of the Company, for the Financial Year ended March 31, 2015.Accordingly the Company will hold the Annual General Meeting on or before December 31, 2015.

Opto Circuits (India) Limited has informed the Exchange that "Opto Cardiac Care Limited, a subsidiary of Opto Circuits (India) Limited has been successful in getting back Criticare Systems Inc USA, which was placed in Chapter 128 (Bankruptcy Court) by Aurora Capital, who bought the loan from our lender DBS Bank Limited. Criticare Systems Inc, is now back as part of the Opto Group of Companies".

Opto Circuits (India) Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from December 29, 2015 to December 31, 2015 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on December 31, 2015.

Opto Circuits (India) Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-Sep-2015.

Opto Circuits (India) Limited has informed the Exchange that the Trading Window for dealing in the securities of the Company will remain closed for all Directors/Officers/Designated employees of the company from November 6, 2015 to November 16, 2015 (both days inclusive).

Opto Circuits (India) Limited has informed the Exchange that one of the Company's subsidiary company, viz Cardiac Science Corporation, USA, has filed voluntary petition under Chapter 11 of the US Bankruptcy Code to Facilitate Debt Restructuring in US Bankruptcy Courts in the Western District of Wisconsin on October 20, 2015.The above action is initiated by the secured lenders to the Company for such filing and the management of Opto Circuits (India) Limited is taking effective legal recourse required in this regard.

Opto Circuits (India) Limited has informed the Exchange that one of the step down overseas subsidiary company, viz Cardiac Science Corporation, USA, has filed voluntary petition under Chapter 11 of the US Bankruptcy Codeto Facilitate Debt Restructuring in US Bankruptcy Courts in the Western District of Wisconsin on October 20, 2015.

Opto Circuits (India) Limited has informed the Exchange that in terms of the approval under Companies Act, 2013, the Company has obtained approval from the Office of the Registrar of Companies (ROC), Karnataka, an extension of time for holding AGM of the Company, for the Financial Year ended March 31, 2015. Accordingly the Company will hold the AGM on or before December 31, 2015.

Opto Circuits (India) Limited has informed the Exchange that Ms. Supriya Kulkarni has taken over as Company Secretary of the Company effect from September 12, 2015.

Opto Circuits (India) Limited has informed the Exchange that Mr. V. Sundar is appointed as the Chief Financial Officer (CFO) of the Company with effect from September 12, 2015.

Opto Circuits (India) Limited has informed the Exchange that the in view of current market conditions, the GDR issue of the company has been deferred till further notice.

Opto Circuits (India) Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-Jun-2015.

Opto Circuits (India) Limited has informed the Exchange that as per the Company's Code of Conduct for prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will remain closed for all Directors/Officers/Designated employees of the company from August 6, 2015 to August 17, 2015 (both days inclusive) for purpose of declaration of Un-audited Financial Results for the period ended June 30, 2015.

The Exchange had sought clarification from Opto Circuits (India) Limited with respect to announcement dated June 16, 2015 that "The GDR Committee of the Company in its meeting held on June 16 2015 has approved the opening of issue of GDRs of the Company. Accordingly the issue of GDRs of the Company will open on June 16 2015". On basis of above, the reply from the Company is attached.

The Exchange has sought clarification from Opto Circuits (India) Limited with respect to announcement dated June 16, 2015 that "The GDR Committee of the Company in its meeting held on June 16 2015 has approved the opening of issue of GDRs of the Company. Accordingly the issue of GDRs of the Company will open on June 16 2015". On basis of above the Company is required to clarify following: a) Type of securities proposed to be issued b) Total number of securities proposed to be issued or the total amount for which the securities will be issued (approximately) The response of the Compa

Opto Circuits (India) Limited has informed the Exchange that the GDR Committee of the Company, in its meeting held on June 16, 2015 has approved the opening of issue of GDRs of the Company. Accordingly, the issue of GDRs of the Company will open on June 16, 2015.

Opto Circuits (India) Limited has informed the Exchange regarding the press release dated June 08, 2015 titled, "Opto Circuits Group Company-Cardiac Science Corporation Wins Nearly $23 Million, against Zoll in case over wearable defibrillator Technology."

Opto Circuits (India) Limited has informed the Exchange regarding the press release on Audited Finacial Result for the year ended March 31, 2015.

Opto Circuits (India) Limited has submitted to the exchange the standalone financial results for the period ended 31-Mar-2015.

Opto Circuits (India) Limited has submitted to the exchange the consolidated financial results for the period ended 31-Mar-2015.

Opto Circuits (India) Limited has informed the Exchange that as per the Company's Code of Conduct for prevention of Insider Trading, the Trading Window for the purpose of trading in the shares of the Company will remain closed from May 22, 2015 to May 31, 2015 (both days inclusive) inter alia to consider Audited Financial Results for the year ended March 31, 2015. The trading window shall open from June 1, 2015.

Opto Circuits (India) Limited has informed the Exchange that in Compliance with SEBI (Prohibition of Insider Trading) Regulation, 2015 and SEBI dated May 11, 2015 that Company informs that the Company has formulated and published on its website, the code of Practices and Procedure for Fair Disclosure of Unpublised Price Sensitive Information and Code of Conduct for Prevention of Insider Trading. Copy enclosed.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated May 13, 2015 titled "Opto Circuits Group Company, Cardiac Science, Introduces Powerheart G5 AED to U.S., Canadian Markets".

Opto Circuits (India) Limited has informed the Exchange that Resignation of CFO Mr. P V Rao has been accepted.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated May 6, 2015 titled "Opto Circuits Group Company - Cardiac Science Receives U.S. FDA 510k Clearance to Market New Powerheart G5 AED with CPRD".

Opto Circuits (India) Limited has informed the Exchange that the Company has appointed Ms. Suchitra Misra, on the Board of Directors of the company whose consent has been received pursuant to the provisions of the Companies Act, 2013 as Woman Director effective from March 31, 2015. The Company would also like to bring to notice the resignation of Mr. Balasubramaniam Visvanathan, Director.

Opto Circuits (India) Limited has submitted to the exchange the standalone financial results for the period ended 31-Dec-2014.

Opto Circuits (India) Limited has informed the Exchange that as per the Company's Code of Conduct for prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will remain closed for all Directors / Officers / Designated employees of the Company from February 6, 2015 to February 13, 2015 (both days inclusive) inter alia for the purpose of announcement of the Un-audited Financial Results of the Company. The trading window shall open from February 16, 2015.

Opto Circuits (India) Limited has informed the Exchange vide letter dated January 16, 2015 about Press Release regarding Eurocor GmbH a group company of Opto Circuits (India) Limited has received CE Mark (Communite European) approval for E-Magic Plus Sirolimus Eluting Coronary Stent System.